164 related articles for article (PubMed ID: 16412248)
1. Pore forming polyalkylpyridinium salts from marine sponges versus synthetic lipofection systems: distinct tools for intracellular delivery of cDNA and siRNA.
McLaggan D; Adjimatera N; Sepcić K; Jaspars M; MacEwan DJ; Blagbrough IS; Scott RH
BMC Biotechnol; 2006 Jan; 6():6. PubMed ID: 16412248
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of the actions of alkylpyridinium salts from a marine sponge and related synthetic compounds in rat cultured hippocampal neurones.
Koss DJ; Hindley KP; David KC; Mancini I; Guella G; Sepcić K; Turk T; Rebolj K; Riedel G; Platt B; Scott RH
BMC Pharmacol; 2007 Feb; 7():1. PubMed ID: 17274812
[TBL] [Abstract][Full Text] [Related]
3. Irreversible and reversible pore formation by polymeric alkylpyridinium salts (poly-APS) from the sponge Reniera sarai.
McClelland D; Evans RM; Abidin I; Sharma S; Choudhry FZ; Jaspars M; Sepcić K; Scott RH
Br J Pharmacol; 2003 Aug; 139(8):1399-408. PubMed ID: 12922926
[TBL] [Abstract][Full Text] [Related]
4. A unique and highly efficient non-viral DNA/siRNA delivery system based on PEI-bisepoxide nanoparticles.
Swami A; Kurupati RK; Pathak A; Singh Y; Kumar P; Gupta KC
Biochem Biophys Res Commun; 2007 Nov; 362(4):835-41. PubMed ID: 17822674
[TBL] [Abstract][Full Text] [Related]
5. Very long chain N4, N9 -diacyl spermines: non-viral lipopolyamine vectors for efficient plasmid DNA and siRNA delivery.
Ghonaim HM; Li S; Blagbrough IS
Pharm Res; 2009 Jan; 26(1):19-31. PubMed ID: 18781381
[TBL] [Abstract][Full Text] [Related]
6. The influence of alkyl pyridinium sponge toxins on membrane properties, cytotoxicity, transfection and protein expression in mammalian cells.
Tucker SJ; McClelland D; Jaspars M; Sepcić K; MacEwan DJ; Scott RH
Biochim Biophys Acta; 2003 Aug; 1614(2):171-81. PubMed ID: 12896810
[TBL] [Abstract][Full Text] [Related]
7. Targeted SAINT-O-Somes for improved intracellular delivery of siRNA and cytotoxic drugs into endothelial cells.
Adrian JE; Morselt HW; Süss R; Barnert S; Kok JW; Asgeirsdóttir SA; Ruiters MH; Molema G; Kamps JA
J Control Release; 2010 Jun; 144(3):341-9. PubMed ID: 20226822
[TBL] [Abstract][Full Text] [Related]
8. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
Kim HK; Davaa E; Myung CS; Park JS
Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
[TBL] [Abstract][Full Text] [Related]
9. The efficiency of CD40 down regulation by siRNA and antisense ODN: comparison of lipofectamine and FuGENE6.
Ebadi P; Karimi MH; Pourfathollah AA; Saheb Ghadam Lotfi A; Soheili ZS; Samiee S; Hajati S; Nadali F; Geramizadeh B; Moazzeni SM
Iran J Immunol; 2009 Mar; 6(1):1-11. PubMed ID: 19293472
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of VEGF expression in A431 and MDA-MB-231 tumour cells by cationic lipid-mediated siRNA delivery.
Briane D; Slimani H; Tagounits A; Naejus R; Haddad O; Coudert R; Charnaux N; Cao A
J Drug Target; 2012 May; 20(4):347-54. PubMed ID: 22475204
[TBL] [Abstract][Full Text] [Related]
11. Novel cholesterol spermine conjugates provide efficient cellular delivery of plasmid DNA and small interfering RNA.
Maslov MA; Kabilova TO; Petukhov IA; Morozova NG; Serebrennikova GA; Vlassov VV; Zenkova MA
J Control Release; 2012 Jun; 160(2):182-93. PubMed ID: 22138073
[TBL] [Abstract][Full Text] [Related]
12. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
Spagnou S; Miller AD; Keller M
Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
[TBL] [Abstract][Full Text] [Related]
13. A comparative evaluation of poly-L-lysine-palmitic acid and Lipofectamine 2000 for plasmid delivery to bone marrow stromal cells.
Clements BA; Incani V; Kucharski C; Lavasanifar A; Ritchie B; Uludağ H
Biomaterials; 2007 Nov; 28(31):4693-704. PubMed ID: 17686514
[TBL] [Abstract][Full Text] [Related]
14. Anionic amino acid-derived cationic lipid for siRNA delivery.
Suh MS; Shim G; Lee HY; Han SE; Yu YH; Choi Y; Kim K; Kwon IC; Weon KY; Kim YB; Oh YK
J Control Release; 2009 Dec; 140(3):268-76. PubMed ID: 19567256
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of carrier-mediated siRNA delivery: lessons for the design of a stem-loop qPCR-based approach for quantification of intracellular full-length siRNA.
Colombo S; Nielsen HM; Foged C
J Control Release; 2013 Mar; 166(3):220-6. PubMed ID: 23313963
[TBL] [Abstract][Full Text] [Related]
16. 1,4-Butanediol diglycidyl ether (BDE)-crosslinked PEI-g-imidazole nanoparticles as nucleic acid-carriers in vitro and in vivo.
Goyal R; Bansal R; Tyagi S; Shukla Y; Kumar P; Gupta KC
Mol Biosyst; 2011 Jun; 7(6):2055-65. PubMed ID: 21505659
[TBL] [Abstract][Full Text] [Related]
17. Efficient and safe delivery of siRNA using anionic lipids: Formulation optimization studies.
Kapoor M; Burgess DJ
Int J Pharm; 2012 Aug; 432(1-2):80-90. PubMed ID: 22575754
[TBL] [Abstract][Full Text] [Related]
18. Rapid delivery of small interfering RNA by biosurfactant MEL-A-containing liposomes.
Inoh Y; Furuno T; Hirashima N; Kitamoto D; Nakanishi M
Biochem Biophys Res Commun; 2011 Oct; 414(3):635-40. PubMed ID: 22001930
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects induced by polymeric 3-alkylpyridinium salts from the marine sponge Reniera sarai.
Lunder M; Drevenšek G; Hawlina S; Sepčić K; Ziberna L
Toxicon; 2012 Nov; 60(6):1041-8. PubMed ID: 22846421
[TBL] [Abstract][Full Text] [Related]
20. Efficient intracellular siRNA delivery strategy through rapid and simple two steps mixing involving noncovalent post-PEGylation.
Kong WH; Sung DK; Shim YH; Bae KH; Dubois P; Park TG; Kim JH; Seo SW
J Control Release; 2009 Sep; 138(2):141-7. PubMed ID: 19426771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
